Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 7,436 | 6,140 | 5,923 | 5,820 | 6,029 |
| Operating Income | -7,436 | -6,140 | -5,923 | -5,820 | -6,029 |
| Other Income | 1 | 0 | 5 | 1 | 1 |
| Pre-tax Income | -7,435 | -6,140 | -5,918 | -5,819 | -6,028 |
| Net Income Continuous | -7,435 | -6,140 | -5,918 | -5,819 | -6,028 |
| Net Income | $-7,435 | $-6,140 | $-5,918 | $-5,819 | $-6,028 |
| EPS Basic Total Ops | -36.64 | -30.03 | -28.23 | -29.13 | -34.23 |
| EPS Basic Continuous Ops | -36.54 | -30.18 | -27.33 | -29.19 | -34.31 |
| EPS Diluted Total Ops | -36.64 | -30.03 | -28.23 | -29.13 | -34.23 |
| EPS Diluted Continuous Ops | -36.54 | -30.18 | -27.33 | -29.19 | -34.31 |
| EBITDA(a) | $-7,402 | $-6,097 | $-5,884 | $-5,783 | $-5,990 |